Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis | PLOS ONE
Overall survival with chemotherapy involving bevacizumab in mcrc... | Download Scientific Diagram
Landmark OS for HCC, updated IMbrave150 data - Medical Conferences
Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with (“pseudo-randomized”) treatment allocation by the health insurance provider | SpringerLink
Overall survival and time to treatment failure for patients eligible... | Download Scientific Diagram
Bevacizumab and chemotherapy for recurrent glioblastoma | Neurology
A Phase 3 Trial of Bevacizumab in Ovarian Cancer | NEJM
Bevacizumab in First-line Therapy of Metastatic Colorectal Cancer: A Retrospective Comparison of FOLFIRI and XELIRI | Anticancer Research
Figure 3 from Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial. | Semantic Scholar
Bevacizumab in the Management of Epithelial Ovarian Cancer | touchONCOLOGY
Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancer
Panitumumab beats bevacizumab in RAS wildtype left-sided metastatic colorectal cancer - Medical Conferences
Avastin® (bevacizumab) Clinical Trials | MCRC Treatment
Avastin® (bevacizumab) Clinical Trials | MRCC Treatment
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial - The Lancet Respiratory
Bevacizumab Plus Standard Chemotherapy Improves Survival in Mesothelioma - The ASCO Post
Adding Olaparib to Bevacizumab Maintenance Improves Progression
Avastin® (bevacizumab) Clinical Trials | CC Treatment
Avastin® (bevacizumab) Clinical Trials for Ovarian Cancer | HCP
Kaplan-Meier Estimates of Progression-free and Overall Survival,... | Download Scientific Diagram
Overall survival for patients randomized to receive (A) bevacizumab (n... | Download Scientific Diagram
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study - ScienceDirect
Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study | Anticancer Research
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study - ScienceDirect
